Skip to content
AnthologyRX

Does Semax/Selank work?

The cited research gives reasons to study Semax and Selank. It does not establish that the compounded combination improves everyday focus or anxiety in people.

Semax/Selank is not currently offered through AnthologyRX. This guide remains available for general information.

Mechanism studies are a starting point

The Semax paper examined BDNF-related signaling in rat hippocampus. The Selank paper examined gene expression in rat frontal cortex. Neither study tested the finished combination, work performance or an anxiety-treatment outcome in humans.

Read: Dolotov et al. Semax and BDNF in rat hippocampus; Volkova et al. Selank and gene expression in rats.

Do nasal-spray studies support the injection?

The preparation previously listed here combines Semax and Selank in an injection. FDA’s briefing for its July 2026 advisory meeting found intranasal human Semax literature but no literature discussing subcutaneous administration. Studies of one ingredient given through the nose do not establish the effects or safety of this combined injection.

The briefing also distinguishes Semax free base from its acetate salt. Confirm the exact preparation being considered; a shared ingredient name does not make different products interchangeable.

Read: FDA: Semax briefing for the July 2026 advisory meeting.

What would stronger evidence look like?

A relevant study would identify the patient group, use the same ingredients and route, compare against placebo or appropriate care, and measure a meaningful change. Ingredient-level research does not establish the combination’s benefit or ideal dosing schedule.

Start with the problem, not a label

Describe whether the concern is persistent worry, trouble concentrating, poor sleep or a recent change in function. These can call for different evaluations. Review current medicines and ask how the proposal compares with established care for the identified problem. A non-stimulant description does not establish freedom from interactions or equivalent results.

Sources

  1. Dolotov et al. Semax and BDNF in rat hippocampus

    Brain Research, 2006. Animal mechanism study.

  2. Volkova et al. Selank and gene expression in rats

    Frontiers in Pharmacology, 2016. Animal mechanism study.

  3. FDA: Semax briefing for the July 2026 advisory meeting

    Pages 37–40 distinguish intranasal human reports from the absence of identified subcutaneous safety literature. This is a staff evidence review, not drug approval.

  4. FDA: Compounding questions and answers

    The distinction between compounded medications and FDA-approved drug products.

AnthologyRX
Find your treatment
Browse all treatments